PDEX · Pro Dex Inc
$55.00
+0.33 (+0.60%)
At close · Jul 24
Market Cap
$174.55M
Shares
3.19M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$66.59M
+23.7%
FY2025
Net Income
$8.98M
+322.1%
FY2025
Gross Margin
29.3%
+2.3pp
FY2025
Operating Margin
16.05%
+2.7pp
FY2025
Diluted EPS
$2.67
+345%
FY2025
Operating Cash Flow
-$1.68M
-127%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $74.64M | $66.59M | $53.84M | $46.09M | $42.04M | $38.03M | $34.83M | $27.17M | $22.47M | $21.94M | $20.16M | $13.38M | $10.81M | $722K | $6.71M | $24.06M | |
| $53.9M | $47.08M | $39.29M | $33.34M | $28.91M | $24.45M | $21.69M | $17.39M | $14.52M | $14.76M | $14.27M | $9.68M | $7.85M | $8.53M | $11.84M | $13.92M | |
| $20.73M | $19.51M | $14.55M | $12.75M | $13.13M | $13.58M | $13.14M | $9.78M | $7.94M | $7.19M | $4.92M | $3.7M | $2.97M | $3.72M | $5.42M | $10.14M | |
| — | 29.3% | 27.02% | 27.66% | 31.24% | 35.7% | 37.73% | 35.99% | 35.36% | 32.75% | 24.4% | 27.68% | 27.43% | 514.68% | 80.72% | 42.15% | |
| $3.23M | $3.64M | $3.19M | $2.8M | $2.98M | $4.38M | $2.32M | $1.88M | $1.89M | $1.23M | $1.2M | $1.67M | $1.48M | $1.79M | $2.07M | $1.89M | |
| $5.01M | $4.84M | $4.07M | $4.03M | $4.9M | $4.08M | $3.19M | $2.49M | $2.29M | $2.53M | $1.88M | $1.96M | $1.71M | $2.57M | $3.18M | $3.17M | |
| — | $28K | $28K | $37K | $16K | $14K | $14K | $22K | $20K | $20K | $117K | $44K | — | — | — | — | |
| — | $1.24M | $1.16M | $857K | $726K | $686K | $573K | $438K | $557K | $555K | $614K | $578K | $527K | $582K | $647K | $697K | |
| $9.93M | $8.82M | $7.38M | $6.99M | $8.01M | $9.05M | $6.08M | $4.78M | $5.55M | $4.45M | $4.11M | $4.61M | $3.78M | $5.61M | $6.78M | $6.66M | |
| $10.81M | $10.69M | $7.17M | $5.76M | $5.12M | $4.53M | $7.07M | $5M | $2.39M | $2.74M | $807K | -$902K | -$814K | -$1.9M | -$1.37M | $3.48M | |
| — | 16.05% | 13.32% | 12.5% | 12.19% | 11.9% | 20.28% | 18.39% | 10.65% | 12.47% | 4% | -6.74% | -7.53% | -262.47% | -20.34% | 14.46% | |
| — | $11.93M | $8.33M | $6.62M | $5.85M | $5.21M | $7.64M | $5.44M | $2.95M | $3.29M | $1.42M | -$324K | -$287K | -$1.31M | -$718K | $4.18M | |
| $769K | $829K | $558K | $533K | $464K | $352K | $236K | $220K | $7000 | $12K | $37K | $6000 | $8000 | $11K | -$36K | -$148K | |
| — | — | — | — | — | — | — | — | — | — | — | $6000 | $12K | — | — | — | |
| $3.95M | $1.37M | -$4.54M | $3.67M | $571K | $3.09M | $836K | $449K | $218K | $15K | $321K | $456K | $59K | -$8000 | -$36K | $148K | |
| — | — | — | — | $61K | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | $28K | $1.33M | $25K | $356K | — | — | — | — | — | — | — | — | |
| $16.09M | $12.06M | $2.63M | $9.43M | $5.69M | $7.62M | $7.9M | $5.45M | $2.61M | $2.75M | $1.13M | -$446K | -$755K | -$1.9M | -$1.4M | $3.33M | |
| $4.09M | $3.08M | $507K | $2.35M | $1.12M | $1.45M | $1.79M | $1.3M | $989K | -$2.09M | $25K | -$44K | -$104K | -$39K | -$441K | $530K | |
| $12M | $8.98M | $2.13M | $7.07M | $4.57M | $6.17M | $6.11M | $4.15M | $1.62M | $5.08M | $822K | -$365K | -$488K | -$1.78M | -$876K | $2.64M | |
| — | 13.48% | 3.95% | 15.35% | 10.88% | 16.22% | 17.55% | 15.27% | 7.22% | 23.17% | 4.08% | -2.73% | -4.51% | -247.09% | -13.06% | 10.97% | |
| — | — | — | — | — | $5.82M | $5.08M | $3.75M | $1.44M | $5.12M | $822K | — | — | — | — | — | |
| USD/shares | — | $2.73 | $0.61 | $1.98 | $1.26 | $1.63 | $1.56 | $0.99 | $0.38 | $1.26 | $0.20 | -$0.09 | — | — | -$0.27 | $0.81 |
| USD/shares | — | $2.67 | $0.60 | $1.95 | $1.21 | $1.57 | $1.50 | $0.97 | $0.37 | $1.25 | $0.20 | -$0.09 | — | — | -$0.27 | $0.80 |
| shares | — | 3.29M | 3.5M | 3.57M | 3.64M | 3.8M | 3.91M | 4.19M | 4.3M | 4.04M | 4.14M | 4.17M | 3.49M | 3.32M | 3.27M | 3.26M |
| shares | — | 3.36M | 3.57M | 3.64M | 3.76M | 3.94M | 4.08M | 4.3M | 4.34M | 4.08M | 4.17M | 4.17M | 3.49M | 3.32M | 3.27M | 3.29M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2012–FY2025: $24.22M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Instruments & Supplies median 2.09×
EV/EBIT
—
Medical Instruments & Supplies median 28.36×
P/E (TTM)
15.23×
Medical Instruments & Supplies median 35.84×